U.S. Metastatic Prostate Cancer Diagnoses Increase After Reduction in PSA Screening
A reduction in prostate-specific antigen (PSA) screening in men aged 40 years and older was associated with an increase in... Read More
A reduction in prostate-specific antigen (PSA) screening in men aged 40 years and older was associated with an increase in... Read More
New recommendations for using next-generation sequencing in the setting of metastastic cancer have been published by the European Society for... Read More
Prostate cancer is the most commonly diagnosed cancer in US men, with an estimated 161,360 new cases and 26,730 deaths... Read More
Localized tumors from men with deleterious BRCA2 mutations were genetically more similar to metastatic cancer than to localized sporadic cancer... Read More